Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Vienna, AUT
Campus Vienna Biocenter 4
Dr. Bohr-Gasse 3
Vienna, A-1030, AUT

People

President, Founfer & CSO
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Director, Business Development
Director of Vienna Operations
Director of US Operations
Show All People

Funding

TOTAL $30.4M
FUNDING TOTAL $30.4M
Venture Round, 9/2010
$400k
Series A, 2/2011
OrbiMed Advisors
Polaris Partners
SV Life Sciences
$10M
Series B, 9/2013
Neomed Management
OrbiMed Advisors
Polaris Partners
SV Life Sciences
$20M

Tags

Arsanis

Arsanis, Inc. was incorporated in 2010 and is based in Lebanon, New Hampshire. Arsanis also operates as Arsanis Biosciences in Vienna, Austria, and according to a job posting, the company is focused on developing infectious disease treatments based on similar bacterial protein and carbohydrate antigens as GlycoFi.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. Arsanis closes Series A financing for $10 million (news-medical.net) [edit]
  3. Arsanis, Inc. Closes $20 Million Series B Financing (biospace.com) [edit]
Edit This Page
Last Edited 1/31/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy